Alaunos Therapeutics Inc (TCRT) — Cash Flow-to-Debt Ratio
Alaunos Therapeutics Inc (TCRT) has a Cash Flow-to-Debt Ratio of -0.35x as of June 2026, meaning its operating cash flow of $-300.00K could theoretically repay 0% of its total liabilities ($864.00K) in one year. See TCRT financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Alaunos Therapeutics Inc Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Alaunos Therapeutics Inc across 25 annual periods. For the full cash flow conversion analysis, see how efficiently does Alaunos Therapeutics Inc generate cash.
Annual Cash Flow-to-Debt Ratio for Alaunos Therapeutics Inc (2001–2025)
Year-by-year debt coverage analysis for Alaunos Therapeutics Inc. Check Alaunos Therapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.53x | $-2.87 Million | $813.00K | ▲ +50.9% |
| 2024 | -7.18x | $-4.97 Million | $692.00K | ▲ +53.4% |
| 2023 | -15.41x | $-30.14 Million | $1.96 Million | ▼ -1290.8% |
| 2022 | -1.11x | $-29.23 Million | $26.38 Million | ▲ +33.6% |
| 2021 | -1.67x | $-61.47 Million | $36.81 Million | ▲ +34.5% |
| 2020 | -2.55x | $-57.01 Million | $22.36 Million | ▲ +12.0% |
| 2019 | -2.90x | $-40.85 Million | $14.10 Million | ▲ +44.4% |
| 2018 | -5.21x | $-49.46 Million | $9.49 Million | ▼ -1830.2% |
| 2017 | -0.27x | $-54.67 Million | $202.41 Million | ▲ +15.0% |
| 2016 | -0.32x | $-58.33 Million | $183.65 Million | ▼ -210633.6% |
| 2015 | 0.00x | $-10.00K | $66.35 Million | ▲ +100.0% |
| 2014 | -3.22x | $-36.65 Million | $11.40 Million | ▼ -20.9% |
| 2013 | -2.66x | $-59.51 Million | $22.37 Million | ▼ -18.0% |
| 2012 | -2.25x | $-78.83 Million | $34.96 Million | ▼ -111.9% |
| 2011 | -1.06x | $-38.84 Million | $36.50 Million | ▼ -67.3% |
| 2010 | -0.64x | $-19.69 Million | $30.97 Million | ▼ -11.9% |
| 2009 | -0.57x | $-12.29 Million | $21.63 Million | ▲ +85.9% |
| 2008 | -4.03x | $-23.52 Million | $5.83 Million | ▼ -18.4% |
| 2007 | -3.41x | $-21.65 Million | $6.36 Million | ▲ +29.6% |
| 2006 | -4.84x | $-14.42 Million | $2.98 Million | ▼ -26.3% |
| 2005 | -3.83x | $-8.78 Million | $2.29 Million | ▼ -1003.4% |
| 2004 | -0.35x | $-7.31K | $21.05K | ▲ +4.2% |
| 2003 | -0.36x | $-9.33K | $25.72K | ▲ +45.0% |
| 2002 | -0.66x | $-11.77K | $17.84K | ▲ +88.0% |
| 2001 | -5.50x | $-30.26K | $5.50K | — |